Curaleaf Holdings, Inc. has launched in Florida the Curaleaf Sublingual Tablets, cube-shaped, berry-flavored bites that will provide the state's medical patients with a discreet, sugar-free option.
Packaged in 30-piece jars, Curaleaf's new sublingual tablets contain 5mg of THC per piece, which allows patients to manage their treatment plan with confidence and ease. Each bite, which is made to be ingested orally or sublingually, is translucent in color and features an Arctic Berry flavor.
"The demand for alternative cannabis form functions in Florida has been mounting for years, and we are thrilled to offer our patients an exciting new product — sublingual tablets," said Curaleaf CEO Joe Lusardi. "Our success is driven by listening to and meeting the needs of our patients, and we're incredibly proud to be first to market in Florida with this new option in cannabis medicine. By providing high-quality products in a variety of administration routes, we are better positioned to improve our patients' lives, which has been our mission since Day One."
The new product will be sold at Curaleaf’s 28 operating dispensaries in Florida with a phased roll-out between Aug. 8-20. For more information on the product roll-out cadence, visit the Curaleaf blog.